English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome Journal article
HAO, DP, LI, JJ, WANG, JL, ZHAO, ZQ, Wang, L., Di, L.. Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome[J]. Theranostics, 2019, 3952-3965.
Authors:  HAO, DP;  LI, JJ;  WANG, JL;  ZHAO, ZQ;  Wang, L.; et al.
Favorite |   IF:12.4/12.0 | Submit date：2023/08/30
Ovarian cancer  Estrogen signaling  Deficiency of homologous-recombination  Chemotherapy  Hormone replacement  
Reactive versus Constitutive: Reconcile the Controversial Results about the Prognostic Value of PD-L1 Expression in cancer Journal article
HAO, DP, WANG, GY, Wang, L., Di, L.. Reactive versus Constitutive: Reconcile the Controversial Results about the Prognostic Value of PD-L1 Expression in cancer[J]. Int. J. Biol. Sci, 2019, 1933-1941.
Authors:  HAO, DP;  WANG, GY;  Wang, L.;  Di, L.
Favorite |   IF:8.2/8.3 | Submit date：2023/08/30
PD-L1  CTL  cancer  immunotherapy  microenvironment  
CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-β signaling Journal article
Zhao, ZQ, Hao, DP, Wang, L., LI, JJ, MENG, Y, LI, PP, WANG, Y, ZHANG, C, ZHOU, HS, GARDNER, K, Di, L.. CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-β signaling[J]. Oncogene, 2018, 1-16.
Authors:  Zhao, ZQ;  Hao, DP;  Wang, L.;  LI, JJ;  MENG, Y; et al.
Favorite |   IF:6.9/7.5 | Submit date：2023/08/30
CtBP  Cholesterol  Metastasis